125 related articles for article (PubMed ID: 2421780)
21. Modulation of plasminogen activator production by interleukin 1: differential responses of fibroblasts derived from human skin and rheumatoid and non-rheumatoid synovium.
Andrews HJ; Cawston TE; Hazleman BL
Biochim Biophys Acta; 1990 Jan; 1051(1):84-93. PubMed ID: 2297544
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
Crutchley DJ; Conanan LB; Maynard JR
J Pharmacol Exp Ther; 1982 Sep; 222(3):544-9. PubMed ID: 7050342
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of bone resorption in organ culture by cholera toxin.
Tashjian AH; Ivey JL
Biochem Biophys Res Commun; 1981 Oct; 102(3):1055-64. PubMed ID: 6171290
[No Abstract] [Full Text] [Related]
24. Regulation of bradykinin-induced cyclic amp response by quinacrine and prostaglandin E2 and F2 alpha in human synovial fibroblasts.
Fahey JV; Newcombe DS
Inflammation; 1979 Jul; 3(3):235-42. PubMed ID: 225265
[TBL] [Abstract][Full Text] [Related]
25. Cholera toxin-sensitive 3',5'-cyclic adenosine monophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A.
Liu YF; Civelli O; Zhou QY; Albert PR
Mol Endocrinol; 1992 Nov; 6(11):1815-24. PubMed ID: 1282671
[TBL] [Abstract][Full Text] [Related]
26. Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase.
Tank AW; Ham L; Curella P
Mol Pharmacol; 1986 Nov; 30(5):486-96. PubMed ID: 2430169
[TBL] [Abstract][Full Text] [Related]
27. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.
Vitti G; Hamilton JA
Arthritis Rheum; 1988 Aug; 31(8):1046-51. PubMed ID: 3136776
[TBL] [Abstract][Full Text] [Related]
28. Differential release of plasminogen activator and latent collagenase from mononuclear cell-stimulated synovial cells.
Golds EE; Ciosek CP; Hamilton JA
Arthritis Rheum; 1983 Jan; 26(1):15-21. PubMed ID: 6297507
[TBL] [Abstract][Full Text] [Related]
29. Effects of prostaglandin E2, indomethacin, trifluoperazine and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells.
Dayer JM; Roelke MS; Krane SM
Biochem Pharmacol; 1984 Sep; 33(18):2893-9. PubMed ID: 6089839
[TBL] [Abstract][Full Text] [Related]
30. Regulation of plasminogen activation in rat cell lines.
Reinders JH; Kaczmarek P; van Giezen JJ; Jansen JW
Ann N Y Acad Sci; 1992 Dec; 667():194-8. PubMed ID: 1285021
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway.
DiBattista JA; Martel-Pelletier J; Fujimoto N; Obata K; Zafarullah M; Pelletier JP
Lab Invest; 1994 Aug; 71(2):270-8. PubMed ID: 8078306
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1 stimulation of phospholipase activity in rat synovial fibroblasts. Possible regulation by cyclooxygenase products.
Godfrey RW; Johnson WJ; Hoffstein ST
Arthritis Rheum; 1988 Nov; 31(11):1421-8. PubMed ID: 2847761
[TBL] [Abstract][Full Text] [Related]
33. Rheumatoid synovial cell hormone responses modulated by cell-cell interactions.
Goldring SR; Dayer JM; Krane SM
Inflammation; 1984 Mar; 8(1):107-21. PubMed ID: 6325342
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor alpha, tumor necrosis factor beta (lymphotoxin), interleukin-1 alpha, and interleukin-1 beta.
Butler DM; Vitti GF; Leizer T; Hamilton JA
Arthritis Rheum; 1988 Oct; 31(10):1281-9. PubMed ID: 3140820
[TBL] [Abstract][Full Text] [Related]
35. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
Ransjö M; Fredholm BB; Lerner UH
Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of the plasminogen activator activity of human synovial fibroblasts by retinoids.
Hamilton JA
Arthritis Rheum; 1982 Apr; 25(4):432-40. PubMed ID: 7200364
[TBL] [Abstract][Full Text] [Related]
37. Clonal heterogeneity of cyclic AMP responsiveness: a comparison of malignant murine lymphoid cell lines.
Burchiel SW; Hanson K; Warner NL
Int J Immunopharmacol; 1984; 6(1):35-42. PubMed ID: 6202649
[TBL] [Abstract][Full Text] [Related]
38. Rheumatoid synovial cell morphologic changes induced by a mononuclear cell factor in culture.
Baker DG; Dayer JM; Roelke M; Schumacher HR; Krane SM
Arthritis Rheum; 1983 Jan; 26(1):8-14. PubMed ID: 6297509
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.
Goto T; Herberman RB; Maluish A; Strong DM
J Immunol; 1983 Mar; 130(3):1350-5. PubMed ID: 6185577
[TBL] [Abstract][Full Text] [Related]
40. IL-1 regulation of transin/stromelysin transcription in rheumatoid synovial fibroblasts appears to involve two antagonistic transduction pathways, an inhibitory, prostaglandin-dependent pathway mediated by cAMP, and a stimulatory, protein kinase C-dependent pathway.
Case JP; Lafyatis R; Kumkumian GK; Remmers EF; Wilder RL
J Immunol; 1990 Dec; 145(11):3755-61. PubMed ID: 2174073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
